None listed
Conditions
Brief summary
The aim of this study is to determine whether treatment with prescribed medicinal cannabis (containing delta 9-THC) for long-term symptom control impacts driving and cognitive/psychomotor performance. This will be assessed after 4, 8 and 12 weeks of treatment and examined relative to pre-treatment performance in a group of chronic non-cancer pain patients.
Interventions
This observational study will track chronic pain patients over 3 months as they begin treatment with medical cannabis. Participants will attend four (4) lab sessions (pre-treatment & 1, 2 and 3-months post treatment initiation) in which driving and cognitive performance will be assessed. This trial does not involve any medical interventions. These lab sessions will run for 3-4 hours.
Sponsors
Swinburne University of Technology
Eligibility
Sex/Gender
All
Age
21 Years to No maximum
Healthy volunteers
No
Inclusion criteria
• Male/female aged 21 years and over and diagnosed with chronic non-cancer pain • Current and valid prescription for a THC-containing medicinal cannabis product • No non-medical cannabis use in the 3-months prior to study enrolment • Able to attend 4 sessions over a minimum 12-week period
Exclusion criteria
• Patient is unable to provide written informed consent • Patient is pregnant or lactating • Patient has been previously enrolled in the study • Patient is unable to abstain for illicit drug use for 7 days prior to testing • Patient reports any non-medical (i.e., recreational) cannabis use in the past 3 months
Outcome results
None listed